Summary
Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Organon (OGN) Lags Q2 Earnings Estimates
Organon (OGN) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1 per share a year ago.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Organon & Co. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 4,143 | $142,849.46 | $56,137.65 | -$86,711.81 | -60.7% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 183 | $5,397.48 | $2,479.65 | -$2,917.83 | -54.06% |
 Curtis Ellergodt Rothschild Investment LLC | 3,695 | $40,701.41 | $50,104.2 | $9,402.79 | 23.1% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 27,696 | $375,006 | $376,665.6 | $1,659.6 | 0.44% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 200 | $1,434 | $2,721 | $1,287 | 89.75% |
Organon & Co. (OGN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Organon & Co. ever had a stock split?
Organon & Co. Profile
| Pharmaceuticals Industry | Healthcare Sector | Joseph T. Morrissey Jr. CEO | NYSE Exchange | 68622V106 CUSIP |
| US Country | 10,000 Employees | 14 Aug 2026 Last Dividend | - Last Split | 2 Jun 2021 IPO Date |
Overview
Organon & Co. is a healthcare company focused on innovating and providing a range of health solutions specifically tailored towards women's health needs both in the United States and globally. The company's diverse product offering encompasses a variety of prescription therapies and medical devices. Founded in 2020 and headquartered in Jersey City, New Jersey, Organon & Co. has quickly positioned itself as a key player in women's health, extending its reach through a broad spectrum of contraception and fertility treatments, biosimilars, and other healthcare solutions. Their mission extends to addressing critical areas such as cardiovascular health, respiratory conditions, dermatology, bone health, and non-opioid pain management, catering to a wide demographic. Through its commitment to health innovation, Organon & Co. markets its products to a vast network of stakeholders including drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions.
Products and Services
- Nexplanon: A long-acting reversible contraceptive that offers an effective birth control option.
- NuvaRing: A monthly vaginal ring designed for convenient contraception.
- Cerazette: An oral contraceptive pill that helps prevent pregnancy.
- Marvelon: A daily pill that combines progestin and estrogen to prevent pregnancy.
- Follistim AQ: Utilized in assisted reproduction to stimulate the development of multiple ovarian follicles.
- Elonva: An ovarian follicle stimulant for use in assisted reproductive technologies.
- Ganirelix Acetate Injection: An injectable solution that acts as an antagonist in fertility treatments.
- Jada: A solution for treating abnormal postpartum uterine bleeding or hemorrhage.
- Biosimilars Portfolio: Includes immunology products like Brenzys, Renflexis, and Hadlima, along with two oncology products, Ontruzant and Aybintio, offering alternatives to existing biologic medicines.
- Cholesterol-modifying Medicines: Managed under brands such as Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor to help control cholesterol levels.
- Cozaar and Hyzaar: Prescribed for the treatment of hypertension.
- Respiratory Products: Include treatments for asthma under the Singulair, Dulera, Zenhale, and Asmanex brands.
- Seasonal Allergic Rhinitis Treatments: Products like Singulair, Nasonex, Clarinex, and Aerius are aimed at treating seasonal allergies.
- Dermatology Products: Including treatments for skin conditions under the Diprosone and Elocon brands.
- Bone Health Portfolio: Features the Fosamax brand for bone health management.
- Non-opioid Pain Management Products: Offering solutions like Arcoxia, Diprospan, and Celestone for pain management without the use of opioids.
- Proscar: Used in the treatment of symptomatic benign prostatic hyperplasia.
- Propecia: A treatment solution for male pattern hair loss.
